Bioactive Agent Monitoring via Artificial Sensory Experience
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack an effective integration of bioactive agent use monitoring with artificial sensory experiences to detect and address individual attributes, such as health conditions and symptoms, in a comprehensive and integrated manner.
Innovation Solution
A system and method that accepts indications of bioactive agent use and presents an artificial sensory experience programmed to detect effects, utilizing a combination of hardware, software, and firmware to query databases, select prescription medications and artificial sensory experiences, and implement these combinations based on individual attributes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If bioactive agent use monitoring is integrated with artificial sensory experiences, then health outcome detection capability is improved, but system complexity increases
Solution Approach 1:
The patent combines bioactive agent monitoring with artificial sensory experience delivery into a single integrated system. The system accepts indications of bioactive agent use and presents artificial sensory experiences that are programmed to detect effects of the bioactive agent, merging two previously separate functions (monitoring and sensory intervention) into one unified platform that simultaneously tracks health metrics and delivers targeted sensory stimuli
Solution Approach 2:
The system performs multiple functions through a single integrated platform: it accepts and processes bioactive agent use indications, delivers artificial sensory experiences, detects health outcomes, and manages treatment protocols. This multi-functional approach allows the system to serve as both a monitoring device and a therapeutic intervention device, reducing the need for multiple separate systems
2Reliability
If individual attributes are addressed comprehensively, then health outcome management is improved, but information processing requirements increase
Solution Approach 1:
The system segments individual attributes into distinct categories (health conditions, symptoms, bioactive agent responses) and processes each segment through specialized protocols. By dividing the comprehensive health monitoring into manageable segments, the system can address each attribute comprehensively without overwhelming information processing requirements, allowing targeted analysis of specific health parameters
3Ease of operation
If bioactive agent effects are detected through artificial sensory experiences, then symptom management is improved, but program complexity increases
Solution Approach 1:
The artificial sensory experiences are programmed to autonomously detect effects of bioactive agents without requiring manual intervention. The system automatically processes bioactive agent use indications, selects appropriate sensory experiences from a library, delivers them to the individual, and detects outcomes, enabling the system to manage symptoms through self-service operations while maintaining sophisticated detection capabilities
Data Source
AI summary
Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent.